viewCellmid Limited

Cellmid Limited outlines key components for FY2020 growth strategy

Cellmid Limited outlines key components for FY2020 growth strategy

Cellmid Ltd -

Cellmid Limited (ASX:CDY) chief executive officer and managing director Maria Halasz updates Proactive Investors on the company’s key components for its FY2020 growth strategy, which includes an exciting new global product to assist ageing hair. 

Cellmid is a listed company with health and biotechnology divisions.

The CEO said Cellmid was thrilled with the progress the company had made since announcing the strategy in February this year, and excited that their main product had received an "outstanding reception" in the market.

Quick facts: Cellmid Limited

Price: 0.097 AUD

Market: ASX
Market Cap: $12.15 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cellmid Limited named herein, including the promotion by the Company of Cellmid Limited in any Content on the Site, the Company receives from...


Cellmid Limited to supply rapid diagnostic tests to help in new pandemic

Cellmid Limited (ASX:CDY) CEO Maria Halasz tells Proactive's Andrew Scott they've signed an agreement to supply rapid diagnostic tests (RDT), with products expected to arrive in the country by early April. The test uses a virus-specific detection method that delivers results anywhere between...

on 30/3/20

2 min read